Cutia Therapeutics (HK:2487) has released an update. Cutia Therapeutics’ CEO, Ms. Zhang Lele, has further increased her stake in the company by purchasing an additional 5,000 shares, reflecting ...

Cutia Therapeutics (HK:2487) has released an update. Cutia Therapeutics has announced that its CEO, Ms. Zhang Lele, has increased her personal stake in the company by purchasing an additional ...

all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Cutia Therapeutics has successfully completed Phase II trials ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...